- Home
- MMT vs TERN Comparison
MMT vs TERN Comparison
Compare MMT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMT
- TERN
- Stock Information
- Founded
- MMT 1987
- TERN 2017
- Country
- MMT United States
- TERN United States
- Employees
- MMT N/A
- TERN 59
- Industry
- MMT Trusts Except Educational Religious and Charitable
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- MMT Finance
- TERN Health Care
- Exchange
- MMT Nasdaq
- TERN Nasdaq
- Market Cap
- MMT 251.6M
- TERN 263.8M
- IPO Year
- MMT N/A
- TERN 2021
- Fundamental
- Price
- MMT $4.60
- TERN $2.89
- Analyst Decision
- MMT
- TERN Buy
- Analyst Count
- MMT 0
- TERN 5
- Target Price
- MMT N/A
- TERN $15.63
- AVG Volume (30 Days)
- MMT 86.5K
- TERN 948.2K
- Earning Date
- MMT 01-01-0001
- TERN 05-08-2025
- Dividend Yield
- MMT 8.58%
- TERN N/A
- EPS Growth
- MMT N/A
- TERN N/A
- EPS
- MMT 0.30
- TERN N/A
- Revenue
- MMT N/A
- TERN N/A
- Revenue This Year
- MMT N/A
- TERN N/A
- Revenue Next Year
- MMT N/A
- TERN N/A
- P/E Ratio
- MMT $15.33
- TERN N/A
- Revenue Growth
- MMT N/A
- TERN N/A
- 52 Week Low
- MMT $4.04
- TERN $1.87
- 52 Week High
- MMT $4.70
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- MMT 52.91
- TERN 46.50
- Support Level
- MMT $4.59
- TERN $2.66
- Resistance Level
- MMT $4.66
- TERN $3.40
- Average True Range (ATR)
- MMT 0.04
- TERN 0.24
- MACD
- MMT 0.00
- TERN -0.03
- Stochastic Oscillator
- MMT 40.00
- TERN 19.17
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.